Skip to content
10-Q

Quarterly Report

Medicale Corp. MCLE

0001683168-24-003367

← back to feed
Filed
May 14, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · May 14, 2024 5.92M sh
Current Liabilities Q2 2024 · Mar 31, 2024 $12.96K
Current Liabilities Q2 2024 · Sep 30, 2023 $40.88K
Total Liabilities Q2 2024 · Mar 31, 2024 $71.75K
Total Liabilities Q2 2024 · Sep 30, 2023 $40.88K
Current Assets Q2 2024 · Mar 31, 2024 $159
Current Assets Q2 2024 · Sep 30, 2023 $159
Total Assets Q2 2024 · Mar 31, 2024 $159
Total Assets Q2 2024 · Sep 30, 2023 $159
Shares Diluted Q2 2024 · Mar 31, 2023 5.92M sh
Shares Diluted Q2 2024 · Mar 31, 2023 5.92M sh
Operating Cash Flow Q2 2024 · Mar 31, 2023 −$5.26K
Stockholders Equity Q2 2024 · Mar 31, 2023 −$17.96K
Stockholders Equity Q2 2024 · Dec 31, 2022 −$11.84K
Stockholders Equity Q2 2024 · Sep 30, 2022 −$54.77K
Sga Expense Q2 2024 · Mar 31, 2023 $6.12K
Sga Expense Q2 2024 · Mar 31, 2023 $14.83K
Net Income Q2 2024 · Mar 31, 2023 −$6.12K
Net Income Q2 2024 · Mar 31, 2023 −$14.37K
Net Income Q2 2024 · Dec 31, 2022 −$8.26K
Operating Income Q2 2024 · Mar 31, 2023 −$6.12K
Operating Income Q2 2024 · Mar 31, 2023 −$14.83K